A. Fairbairn

发表

Senile dementia of Lewy body type A clinically and neuropathologically distinct form of Lewy body dementia in the elderly

Robert H. Perry, Elaine K. Perry, E. Perry, 1990, Journal of the Neurological Sciences.

Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.

E. Perry, M. Curtis, J. Atack, 1985, Journal of neurology, neurosurgery, and psychiatry.

ALUMINOSILICATES AND SENILE PLAQUE FORMATION IN ALZHEIMER'S DISEASE

E. Perry, J. Klinowski, J. Atack, 1986, The Lancet.

Serum creatine kinase-BB levels and cerebral cortical creatine kinase activity in senile dementia of the Alzheimer type

G. Blessed, R. Perry, N. Ferrier, 1987, Journal of the Neurological Sciences.

Dopamine metabolism in postmortem caudate-nucleus in neurodegenerative disorders

P. Thompson, E. Perry, I. McKeith, 1994 .

Molecular forms of acetylcholinesterase in senile dementia of Alzheimer type: Selective loss of the intermediate (10S) form

Robert H. Perry, Bernard E. Tomlinson, Elaine K. Perry, 1983, Neuroscience Letters.

Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases.

E. Perry, J. Edwardson, G. Blessed, 1987, Journal of neurology, neurosurgery, and psychiatry.

Nigrostriatal dopaminergic activities in dementia with lewy bodies in relation to neuroleptic sensitivity: comparisons with parkinson’s disease

E. Perry, I. McKeith, P. Thompson, 1998, Biological Psychiatry.

Quality of care in private sector and NHS facilities for people with dementia: cross sectional survey

C. Ballard, G. Tadros, A. Fairbairn, 2001, BMJ : British Medical Journal.

Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of meynert in Alzheimer's disease

E. Perry, G. Blessed, D. Irving, 1982, Neuroscience Letters.

Cholinergic Receptors in Cognitive Disorders

E. Perry, D. Purohit, J. Edwardson, 1986, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Transferrin and transferrin receptors in normal brain and in Alzheimer's disease

C. Morris, R. Perry, A. Fairbairn, 1987 .

Prevalence and pharmacological management of behavioural and psychological symptoms amongst dementia sufferers living in care environments

J. O'Brien, A. Swann, C. Ballard, 2001, International journal of geriatric psychiatry.

Operational criteria for senile dementia of Lewy body type (SDLT)

E. Perry, I. McKeith, S. Jabeen, 1992, Psychological Medicine.

Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: Possible index of early neuropathology

D. Irving, E. Perry, I. McKeith, 1995, Neuroscience.

Neuroleptic sensitivity in patients with senile dementia of Lewy body type.

E. Perry, I. McKeith, P. M. Thompson, 1992, BMJ.

Prospective validation of Consensus criteria for the diagnosis of dementia with Lewy bodies

A. Swann, E. Perry, I. McKeith, 2000, Neurology.

The Clinical Diagnosis and Misdiagnosis of Senile Dementia of Lewy Body Type (SDLT)

I. McKeith, P. Thompson, R. Perry, 1994, British Journal of Psychiatry.

An evaluation of the predictive validity and inter‐rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type

I. Ferrier, I. McKeith, P. Thompson, 1994, Neurology.

Muscarinic Cholinergic Receptor Subtypes in Hippocampus in Human Cognitive Disorders

E. Perry, G. Blessed, R. Perry, 1988, Journal of neurochemistry.

Monoaminergic activities in Lewy Body dementia: Relation to hallucinosis and extrapyramidal features

P Thompson, I G McKeith, E K Perry, 1993, Journal of neural transmission. Parkinson's disease and dementia section.

What are the relations between Lewy body disease and AD?

I. McKeith, C. Morris, J. Grace, 1998, Journal of neural transmission. Supplementum.

Cognitive performance of medicated schizophrenics with tardive dyskinesia

D. Collerton, A. Fairbairn, P. Britton, 1985, Psychological Medicine.

CYP2D6 is associated with Parkinson's disease but not with dementia with Lewy Bodies or Alzheimer's disease.

I. McKeith, C. Morris, P. Ince, 1999, Pharmacogenetics.

Depression in late life, cognitive decline and white matter pathology in two clinico‐pathologically investigated cases

I. McKeith, E. Jaros, R. Perry, 2001, International journal of geriatric psychiatry.